RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction

Clinical trial NCT07203521 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07203521
Sponsor: Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Large Hemispheric Infarction Stroke Transcranial Bone Marrow Injection RK-4 Acute Ischemic Stroke

Start date: 2025-11-01
Primary completion: 2026-04-30
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.